Truist Financial Boosts agilon health (NYSE:AGL) Price Target to $6.50

agilon health (NYSE:AGL – Free Report) had its price objective lifted by Truist Financial from $6.40 to $6.50 in a research report released on Friday, Benzinga reports. The firm currently has a hold rating on the stock. Several other research firms also recently commented on AGL. Benchmark dropped their target price on agilon health from […]

Leave a Reply

Your email address will not be published.

Previous post HC Wainwright Lowers Cytokinetics (NASDAQ:CYTK) Price Target to $90.00
Next post Berkshire Hills Bancorp (NYSE:BHLB) Cut to “Sell” at StockNews.com